Fig. 3: Comparative analysis of immune signature expression through supervised gene expression analysis between day 14 samples and surgery tumor specimens, categorized by different treatment arms. | npj Breast Cancer

Fig. 3: Comparative analysis of immune signature expression through supervised gene expression analysis between day 14 samples and surgery tumor specimens, categorized by different treatment arms.

From: Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy

Fig. 3

The numerical values correspond to Fold Change, computed using a two-class paired Significance Analysis of Microarrays (SAM), highlighting alterations. Color-coded boxes identify modules exhibiting significant changes with a false discovery rate (FDR) of ≤ 0.05, with upregulation in red and downregulation in green.

Back to article page